首页 | 本学科首页   官方微博 | 高级检索  
     


Comparison of ixekizumab with ustekinumab in moderate‐to‐severe psoriasis: 24‐week results from IXORA‐S,a phase III study
Authors:K. Reich  A. Pinter  J.P. Lacour  C. Ferrandiz  G. Micali  L.E. French  M. Lomaga  Y. Dutronc  C. Henneges  S. Wilhelm  S. Hartz  C. Paul
Affiliation:1. Dermatologikum Hamburg, Stephansplatz 5, 20354 Hamburg, Germany;2. Georg‐August‐University, Göttingen, Germany;3. Correspondence;4. Kristian Reich.;5. E‐mail:;6. Department of Dermatology, Venereology, and Allergology, University Clinic Frankfurt, Frankfurt am Main, Germany;7. Department of Dermatology, University Hospital of Nice, Nice, France;8. Servicio de Dermatología, Hospital Universitario Germans Trias i Pujol, Universitat Autónoma de Barcelona, Badalona, Barcelona, Spain;9. Dermatology Clinic, University of Catania, University Hospital Policlinico‐Vittorio Emanuele, Catania, Sicily, Italy;10. Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland;11. DermEdge Research, Mississauga, ON, Canada;12. Eli Lilly and Company, Indianapolis, IN, U.S.A.;13. Dermatology Department, CHU, Paul Sabatier University, Toulouse, France
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号